Zelber-Sagi S, Shoham D, Zvibel I, Abu-Abeid S, Shibolet O, Fishman S. Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. World J Hepatol 2017; 9(2): 91-98 [PMID: 28144390 DOI: 10.4254/wjh.v9.i2.91]
Corresponding Author of This Article
Shira Zelber-Sagi, PhD, School of Public Health, University of Haifa, 6 Weizmann St., Haifa 3498838, Israel. zelbersagi@bezeqint.net
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Control Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 Comparison between subjects with fibrosis degree F < 2 and subjects with significant fibrosis degree F ≥ 2 (mean ± SD, unless otherwise stated)
Table 4 Multivariate analysis for the prediction of significant or advanced fibrosis
Variable
Model 1: F ≥ 2
Model 2: F ≥ 3
OR (95%CI)
P
OR (95%CI)
P
Age (yr)
1.03 (0.99-1.08)
0.153
1.03 (0.98-1.07)
0.246
Gender (male)
7.93 (2.36-26.64)
0.001
2.92 (1.08-7.91)
0.035
BMI (kg/m2)
1.33 (1.11-1.60)
0.002
1.17 (1.03-1.33)
0.018
Citation: Zelber-Sagi S, Shoham D, Zvibel I, Abu-Abeid S, Shibolet O, Fishman S. Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. World J Hepatol 2017; 9(2): 91-98